Transition Therapeutics Appoints New Chief Financial Officer
Transition Therapeutics Inc. (NASDAQ: TTHI) today announces the appointment of Ms. Nicole Rusaw-George, C.A., as Chief Financial Officer of Transition. Ms. George has been with the Company since 2005 and has served as Vice-President, Finance since 2008. While at Transition, Ms. George has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.